上海复宏汉霖生物技术股份有限公司(2696)将于2025年12月31日(星期三)上午九时，在中国上海市徐汇区宜州路188号B8幢10楼会议室举行临时股东大会。主要议案包括审议并酌情批准与国药控股股份有限公司签订的“国控经销框架协议(2025重续)”及相关年度上限。
根据公告，自2025年12月24日至12月31日(包括首尾两日)暂停办理股份过户登记。股东如需委派代表参加，应在12月30日上午九时前完成委托手续。于当日名列公司股东名册的股东将有权出席并投票。会议将以投票方式表决，结果将在香港交易及结算所有限公司及公司网站刊发。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.